Capturing the Diversity of Dermatology—What’s in a Name? Taylor EricksonKarishma DaftaryRaj Chovatiya Current Opinion 16 June 2023 Pages: 675 - 680
Targeting Inflammation in Acne: Current Treatments and Future Prospects Sebastian CruzNatalia VecerekNada Elbuluk Leading Article Open access 16 June 2023 Pages: 681 - 694
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review Jonathan K. HwangJose W. RicardoShari R. Lipner Systematic Review 20 May 2023 Pages: 695 - 720
Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis Chia-Ling YuPo-Yi ChouChing-Chi Chi Systematic Review 03 April 2023 Pages: 721 - 730
Atopic Dermatitis Across Shades of Skin Victor L. QuanTaylor EricksonRaj Chovatiya Review Article 19 June 2023 Pages: 731 - 751
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis Diana BernardoThomas BieberTiago Torres Review Article Open access 02 June 2023 Pages: 753 - 764
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies Christopher J. FaySamantha JakuboskiNicole R. LeBoeuf Review Article 03 July 2023 Pages: 765 - 785
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial Elaine C. SiegfriedMichael J. CorkAnnie Zhang Original Research Article Open access 10 June 2023 Pages: 787 - 798
Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study Hao-Hsin HuangDereck ShenChia-Yu Chu Original Research Article 06 June 2023 Pages: 799 - 808
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome Philip J. MeaseGülen HatemiLinda Stein Gold Original Research Article Open access 14 June 2023 Pages: 809 - 820
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials Michael SticherlingArjen F. NikkelsDeborah Keefe Original Research Article Open access 21 June 2023 Pages: 821 - 835
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study Tadashi TeruiYukari OkuboMasamoto Murakami Original Research Article Open access 26 May 2023 Pages: 837 - 847
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights Kathy A. Fraser Meeting Report 21 August 2023 Pages: 849 - 851
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis” Shurong ChenYi Chen Letter to the Editor 27 June 2023 Pages: 853 - 854
Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis” Chia-Ling YuPo-Yi ChouChing-Chi Chi Letter to the Editor 27 June 2023 Pages: 855 - 858
